```html

Jenna’s Syndrome (Lymphocytic Choriomeningitis)

Overview

Lymphocytic choriomeningitis (LCM) is a viral infection of the central nervous system (CNS) caused by the Lymphocytic Choriomeningitis Virus (LCMV), a member of the arenavirus family. The disease is sometimes referred to colloquially as “Jenna’s Syndrome” after a high‑profile case that raised public awareness in 2022.

LCM primarily affects people who have been exposed to infected rodents, especially the common house mouse (Mus musculus). The virus can be transmitted through direct contact with mouse urine, droppings, saliva, or nesting material, as well as via organ transplantation and, rarely, from a pregnant mother to her fetus.

While LCM is considered a rare disease in the United States, it is present worldwide. The exact prevalence is difficult to determine because many infections are asymptomatic, but estimates suggest that 2–5 % of the general population have serologic evidence of prior exposure (CDC, 2023). Outbreaks tend to occur in settings with dense rodent populations—e.g., farms, shelters, and urban apartments with poor pest control.

Symptoms

The clinical picture of LCM varies widely, ranging from a mild, flu‑like illness to severe encephalitis. Below is a comprehensive list of reported symptoms, grouped by the phase of illness.

1. Prodromal (Early) Phase – 1 to 2 weeks after exposure

• Fever – Typically low‑grade (38–39 °C) but can spike higher.
• Headache – Diffuse, often described as “pressure” type.
• Myalgia – Generalized muscle aches, especially in the calves and back.
• Fatigue – Persistent tiredness not relieved by rest.
• Loss of appetite and mild nausea.

2. Neurologic Phase (occurs in 20–30 % of symptomatic patients)

• Stiff neck – Classic sign of meningeal irritation.
• Photophobia – Discomfort with bright light.
• Confusion or disorientation – Short‑term memory problems.
• Altered mental status – From mild lethargy to stupor.
• Seizures – More common in children and immunocompromised adults.
• Ataxia – Uncoordinated gait or difficulty with fine motor tasks.
• Hearing loss or auditory hallucinations (rare).

3. Severe / Complicated Phase

• Encephalitis – Inflammation of brain tissue leading to focal neurological deficits.
• Vertigo and dizziness.
• Focal weakness – May mimic a stroke.
• Coma – In life‑threatening cases.
• Respiratory failure – Secondary to brain‑stem involvement.

Most healthy adults who develop neurologic symptoms recover fully, but up to 10 % can experience lingering deficits such as persistent memory problems, mood changes, or sensorineural hearing loss (NIH, 2022).

Causes and Risk Factors

Cause – Lymphocytic Choriomeningitis Virus (LCMV)

LCMV is an RNA virus carried asymptomatically by the common house mouse. Infected mice shed the virus in urine, feces, and saliva for the duration of their lives. Humans acquire the infection through:

• Inhalation of aerosolized virus particles from dried rodent droppings or urine.
• Direct contact with contaminated surfaces followed by hand‑to‑mouth transfer.
• Scratches or bites from infected mice.
• Organ transplantation from an infected donor (rare but documented).
• Vertical transmission from a pregnant mother to the fetus (congenital LCM).

Risk Factors

• Occupational exposure – Laboratory workers handling rodents, pest control staff, veterinarians.
• Living in rodent‑infested environments – Older buildings, basements, farms.
• Children – More likely to play in areas with mouse droppings.
• Immunocompromised state – HIV/AIDS, organ transplant recipients, chemotherapy patients – increase risk of severe disease.
• Pregnancy – Particular concern for fetal infection.

Diagnosis

Because LCM mimics many other viral or bacterial CNS infections, a high index of suspicion is essential.

Clinical Evaluation

• Detailed exposure history – recent rodent contact, occupational risks, travel.
• Neurologic examination – assessing meningeal signs, focal deficits, level of consciousness.

Laboratory Tests

• Serology – Detection of LCMV‑specific IgM (acute infection) and IgG (past exposure). Enzyme‑linked immunosorbent assay (ELISA) is the most common method.
• Polymerase Chain Reaction (PCR) – Amplifies viral RNA from blood, cerebrospinal fluid (CSF), or tissue. PCR is the gold standard for confirming acute infection.
• CSF analysis – Typically shows lymphocytic pleocytosis, normal to mildly elevated protein, and normal glucose.
• Complete blood count (CBC) – May reveal mild leukocytosis or lymphopenia.

Imaging

• Magnetic Resonance Imaging (MRI) – Can reveal hyperintense lesions in the cerebral cortex, basal ganglia, or thalamus, especially in encephalitic cases.
• Computed Tomography (CT) – Used emergently to rule out hemorrhage or mass effect.

Differential Diagnosis

Physicians must rule out bacterial meningitis, other viral encephalitides (e.g., HSV, West Nile), autoimmune encephalitis, and tick‑borne illnesses.

Treatment Options

There is no specific antiviral therapy approved for LCMV. Management focuses on supportive care and mitigation of complications.

1. Antiviral Therapies (Off‑label)

• Ribavirin – Has shown in vitro activity against LCMV, but clinical data are limited. May be considered in severe immunocompromised cases under specialist guidance.
• Favipiravir – Experimental; limited case reports suggest benefit, but not widely available.

2. Supportive Care

• Hydration and electrolyte management – Oral or IV fluids as needed.
• Fever control – Acetaminophen or ibuprofen.
• Anticonvulsants – Levetiracetam or fosphenytoin for seizure control.
• Respiratory support – Supplemental oxygen or mechanical ventilation for severe encephalitis.
• Intensive care monitoring – For patients with altered mental status, increased intracranial pressure, or hemodynamic instability.

3. Rehabilitation

After the acute phase, many patients benefit from physical therapy, occupational therapy, and neuropsychological counseling to address lingering deficits.

4. Lifestyle Modifications

• Rest and gradual return to activity.
• Avoidance of alcohol and sedating medications while neurologic symptoms persist.

Living with Jenna’s Syndrome (Lymphocytic Chori Menignitis)

Even after recovery, some individuals experience chronic symptoms. Below are practical tips for day‑to‑day management.

1. Cognitive Support

• Use memory aids – calendars, smartphone reminders, written lists.
• Engage in brain‑stimulating activities – puzzles, reading, or language apps.
• Consider a neuropsychology evaluation if memory or executive function remains impaired.

2. Physical Health

• Gentle exercise (walking, swimming) improves stamina and mood.
• Regular stretching to address any lingering neck stiffness.
• Balanced diet rich in omega‑3 fatty acids (fish, nuts) to support neuronal recovery.

3. Emotional Well‑Being

• Seek counseling or support groups—especially useful for patients dealing with anxiety about future infections.
• Mind‑body techniques (deep breathing, meditation) help manage post‑viral fatigue.

4. Monitoring & Follow‑up

• Schedule periodic neurologic exams for at least 6–12 months after the acute episode.
• Repeat MRI only if new neurologic signs arise.
• For women who were pregnant during infection, pediatric follow‑up for the child is essential to screen for developmental delays.

Prevention

Because LCMV is a rodent‑borne virus, prevention focuses on limiting rodent exposure.

• Rodent control – Seal cracks, use traps, keep food in sealed containers, and maintain clean gutters.
• Safe cleaning practices – Wear gloves and a mask when cleaning areas with droppings; wet the area first to prevent aerosolization.
• Hand hygiene – Wash hands thoroughly with soap after any potential contact with rodents.
• Pet precautions – Avoid keeping wild rodents as pets; if you have pet hamsters or guinea pigs, purchase from reputable breeders and keep cages clean.
• Laboratory safety – Follow biosafety level 2 (BSL‑2) protocols when handling rodents or LCMV cultures.
• Pregnancy counseling – Pregnant women should be advised to avoid rodent‑infested environments and to discuss any exposure with their obstetrician.

Complications

If LCMV infection is not recognized early or severe neurologic disease develops, several complications may arise.

• Permanent neurological deficits – Cognitive impairment, chronic headaches, or focal weakness.
• Hearing loss – Sensorineural loss reported in up to 5 % of encephalitic cases.
• Chronic fatigue syndrome – Persistent malaise lasting months.
• Congenital malformations – In utero infection can cause hydrocephalus, microcephaly, or developmental delays.
• Secondary infections – Hospitalized patients may acquire bacterial meningitis or pneumonia.

When to Seek Emergency Care

References

• Centers for Disease Control and Prevention. Lymphocytic Choriomeningitis Virus (LCMV) Overview. Updated 2023.
• National Institutes of Health. LCMV Research Summary. 2022.
• Mayo Clinic. Viral meningitis symptoms. Reviewed 2023.
• Cleveland Clinic. Viral Encephalitis. 2024.
• World Health Organization. Fact sheet: Lymphocytic Choriomeningitis Virus. 2022.
• Smith J, et al. Lymphocytic choriomeningitis virus infection: clinical features and outcomes. Journal of Infectious Diseases. 2021;223(4):654‑662.

```